HOME › Research Insight › Rising Incidences of Cancer and AIDS and Development of Enhanced Informatics Solutions to Drive the Growth of the Cell Counting Market
Rising Incidences of Cancer and AIDS and Development of Enhanced Informatics Solutions to Drive the Growth of the Cell Counting Market
The global cell counting market is poised to grow at a CAGR of 6.5% to 7.0% from 2015 to 2020. Factors such as increasing use of cell counting instruments in cancer and AIDS during diagnosis and treatments, development of enhanced informatics solutions and improved image analysis instruments, and increasing R&D spending on stem cell research are driving the growth of the cell counting market.
Hemocytometers are the most extensively used cell counting instruments in research laboratories, diagnostic laboratories, and academic institutions across the globe. The growing healthcare industry and rising medical spending, increasing urbanization, rising number of healthcare facilities, and automation in research laboratories have contributed to the growth of the advanced cell counting instruments such as spectrophotometers and flow cytometers.
The governments of several nations are investing heavily in research and development (R&D) to develop and commercialize new therapeutic solutions using stem cell and cell-based research. In this regard, several countries are promoting cooperative and initiated R&D programs. Increasing research activities and financial support from public-private organizations are impelling the stem cell research industry, which will further drive the demand for cell counting instruments in the future.
Healthcare organizations in emerging countries are constantly in search for ways to tackle diseases such as cancer, AIDS, and other infectious diseases. The trend of economic expansion and government focus on broader welfare policies for their populations has led to the growth of the healthcare sector in emerging economies in the Latin America and Asia-Pacific regions. With the rapidly developing healthcare infrastructure, the access to healthcare services in emerging economies is set to improve. This factor is likely to propel the growth of the global cell counting market. However, instruments such as flow cytometers and multimode readers are relatively newer technologies and require experts with a good knowledge of cell-based assays and software handling. The shortage of knowledgeable and skilled professionals in clinical laboratories is hindering the growth of the cell counting market as hospitals and laboratories are unable to utilize advanced cell counting methods.
Cell Counting Market by Product [Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer) Consumables (Reagent, Assay Kits, Microplate)], End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2020
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252